SPACs Are Back in 2026: What the 2024 SEC Rules Fixed and Didn't

Regulatory Compliance · Accredited Investor Education

SPACs Are Back in 2026: What the 2024 SEC Rules Fixed — and Didn't

By Jeff Barnes, MBA  |  Angel Investors Network  |  July 27, 2026

The SEC adopted final SPAC rules on January 24, 2024. Those rules changed the legal landscape for blank-check companies more than anything since Sarbanes-Oxley changed auditing. They did not fix the fundamental economics. As of July 2026, roughly $25 billion has been raised through 125 SPAC pricings. Q2 2026 alone saw 55 SPAC IPOs raise $9.8 billion, according to Value Add Pulse. That's real activity. It is not 2021. And that distinction matters enormously if you are an accredited investor deciding whether to put capital into SPAC units, common shares, or warrants.

The 2021 Disaster, by the Numbers

I want to be direct about what happened in 2021, because the people pitching 2026 SPACs would prefer you forget.

In 2021, over 600 SPACs launched and raised a combined $162 billion. The names you heard constantly — electric vehicle companies, space tourism ventures, fintech disruptors — merged with SPACs at valuations that had no connection to revenue or earnings. Sponsors collected their 20% founder shares before a single customer was served. Then retail investors who bought in at or near the $10 trust value watched their shares collapse.

By 2023, independent research aggregating de-SPAC performance showed that the average company that went public through a SPAC fell more than 80% from its post-merger peak. Several collapsed entirely. Nikola, Clover Health, and Lordstown Motors were among the most prominent failures. The SPAC warrant market turned graveyard-quiet. Billions of dollars in individual investor wealth evaporated.

That is the baseline. Any honest analysis of 2026 SPACs starts there.

What the 2024 SEC Rules Actually Changed

The SEC's January 2024 amendments were substantive. Here is what they actually did.

Eliminated the PSLRA safe harbor for de-SPAC projections. Before 2024, SPAC sponsors could publish forward-looking financial projections and claim protection under the Private Securities Litigation Reform Act — a shield designed for well-established public companies making cautious guidance, not for blank-check companies projecting 10x revenue growth with no operating history. That protection is gone. Sponsors now face the same liability exposure for projections that traditional IPO underwriters face.

Required enhanced conflict-of-interest disclosure. The new rules mandate specific disclosure about sponsor compensation, including the exact structure of the promote, any fees paid to the sponsor's affiliates, and any arrangements that could cause the sponsor to prefer deal completion over deal quality. This is now in the registration statement, in plain English, not buried in footnotes.

Required financial restatements for warrant accounting. In 2021 and 2022, the SEC forced hundreds of SPACs to restate financials because warrants had been misclassified as equity rather than liabilities. The 2024 rules codified the correct accounting treatment and imposed stricter review of warrant structures.

Required SPAC investors to vote on whether the de-SPAC target qualifies. This sounds procedural. It is actually meaningful because it creates a formal, documented moment where investors must affirm they understand what they're buying.

What the rules did not change: the 20% sponsor promote. The structural conflict remains in place. I'll come back to this.

How SPACs Work: The Primer for Investors Who Weren't Paying Attention in 2021

A Special Purpose Acquisition Company is a shell. It has no operations, no revenue, and no assets other than cash. A sponsor — typically an experienced deal team, private equity firm, or sector expert — raises money from public investors through an IPO. That cash sits in a trust account, invested in Treasury bills, earning interest while the sponsor hunts for an acquisition target.

The SPAC IPO price is typically $10 per unit. Each unit usually contains one share of common stock and a fraction of a warrant — often one-quarter or one-half of a warrant to buy additional shares at $11.50. The trust holds the $10 per share in cash. If the SPAC doesn't complete an acquisition within the stated deadline (typically 18 to 24 months), the trust is liquidated and investors get their $10 back plus interest. That's the floor.

When the sponsor identifies a target, they announce a deal and ask shareholders to vote on it. Shareholders who don't like the deal can redeem their shares for the trust value — the $10 plus interest. Shareholders who believe in the deal hold on and receive shares of the combined public company. The warrants become exercisable after the merger closes, giving holders the right to buy shares at $11.50.

On the surface, this sounds investor-friendly. It has real protections. The risks lie in the structure itself.

The Structural Conflict: The 20% Promote and Why It Never Goes Away

Here is the part no sponsor wants to lead with in their pitch deck.

The SPAC sponsor typically receives 20% of the total post-IPO shares of the SPAC for a nominal purchase price — sometimes as little as $25,000 for shares that represent millions in value if the SPAC completes a deal. These are called founder shares or the "promote." The sponsor earns the promote by completing any acquisition. Not a good acquisition. Any acquisition.

Think about what that means. If the SPAC raises $200 million and the sponsor has 20% founder shares, the sponsor's stake is worth roughly $40 million at trust value before the deal even closes — assuming the stock trades near $10. The sponsor has a massive financial incentive to complete a deal even if the deal is mediocre. Walking away empty-handed means the promote evaporates. Completing a bad deal still delivers tens of millions to the sponsor.

The 2024 SEC rules require sponsors to disclose this conflict clearly. They do not eliminate it. The SEC cannot legislate away misaligned incentives — they can only require that you understand them before you invest.

Some sponsors have voluntarily restructured promotes in response to investor pressure. A few 2025-2026 SPACs have introduced "earnout promotes" where the sponsor only vests the full 20% if the stock exceeds $12 or $14 post-merger. This is a meaningful improvement. It is not universal, and it doesn't fully align incentives.

2021 SPACs vs. 2026 SPACs: A Direct Comparison

The Redemption Right: The Only Reliable Protection You Have

If you invest in a SPAC at or below the trust value, the redemption right is your most powerful tool. Use it.

Before the merger vote closes, shareholders can redeem their shares for the cash in trust — typically $10 per share plus the interest earned on T-bills since the IPO. You do not need to vote against the deal to redeem. You can redeem regardless of how you vote. This is the mechanism that separates SPAC investing from simply buying pre-revenue small-cap stocks on a promise.

The practical implication: if you buy SPAC units at $10 in the IPO and the trust holds $10.30 per share by the time the merger vote comes, your downside is protected to $10.30 if you redeem. Your risk is time-value of money, transaction costs, and the opportunity cost of capital. That is a fundamentally different risk profile than buying shares of a de-SPAC company on the open market after the merger closes.

Most retail investors in 2021 did not understand the difference. They bought de-SPAC shares — post-merger, post-trust-liquidation — on the open market at elevated prices, then held through the collapse. The redemption right was gone. They had no floor.

If you invest in a 2026 SPAC: invest pre-merger, understand the trust value, and know exactly when the redemption deadline falls. Set a calendar reminder. Sponsors count on investors missing redemption windows.

When SPACs Make Sense for Sophisticated Investors

I'm not anti-SPAC. The structure has legitimate uses. Here is when it makes sense.

When the sponsor has a specific, demonstrable edge. A SPAC run by a former Goldman Sachs TMT banker with 15 years of biotech deal experience is a different bet than a celebrity-backed blank check. Look for sponsors whose prior operating or deal history matches the stated target sector. Check whether they've done SPAC deals before and what happened to the companies they took public.

When the trust yield gives you a reasonable return while you wait. With T-bill yields at current levels, a 12-month SPAC trust earns a meaningful return on your $10. If the deal looks bad, you redeem and pocket the interest. If the deal looks good, you hold. This optionality has real value.

When the target is identifiable and has revenue. Some 2026 SPACs name the target company or describe it with enough specificity that you can do diligence before the vote. Revenue-generating targets with verifiable financials are categorically different from the pre-revenue speculations of 2021.

SPACs make the least sense when: You are buying post-merger on the open market, when the promote is unconditional and large relative to deal size, when the sponsor has no clear sector expertise, or when warrant dilution at exercise would materially dilute your equity position.

The 3 SPAC Structures You'll See and How to Evaluate Each

1. Units

Units are the combination of common shares and warrants sold together in the SPAC IPO. One unit typically contains one share and some fraction of a warrant — you see structures like 1/4 warrant, 1/3 warrant, or 1/2 warrant per unit. Units trade together initially, then separate after 52 days.

Evaluate units by: the per-unit price relative to trust NAV, the warrant terms (exercise price, expiration date), and the sponsor's stated target sector. Buying units at $10 when trust NAV is $10 gives you a zero-premium entry with embedded warrant optionality. That's the cleanest trade structure in the SPAC universe.

2. Common Shares (Post-Separation)

After units separate, the common shares trade independently. If the common trades below trust NAV — which happens when the market doubts the sponsor will find a good deal — you have an arbitrage opportunity: buy below NAV, redeem at NAV if the deal is bad. If the common trades above NAV, you're paying a premium for deal speculation, and your downside protection is limited to redemption at the lower trust value.

The key metric: always know the current trust NAV per share. Your brokerage won't show it to you automatically. You find it in the SPAC's SEC filings — specifically the quarterly 10-Q or the 8-K announcing trust updates.

3. Warrants

SPAC warrants are speculative instruments. Full stop. A warrant gives you the right to buy one share at $11.50 after the merger closes. If the de-SPAC company's shares trade below $11.50, the warrant is worthless. If the stock trades at $15, the warrant is worth approximately $3.50.

Most 2021 SPAC warrants are worthless today. The stocks collapsed below $11.50 and never recovered. Warrants issued by those SPACs expired with zero value. If you buy SPAC warrants in 2026, understand that you are making a leveraged bet on the post-merger stock trading above $11.50. That is not a value investment. It is speculation. Treat it like one.

One legitimate use case: warrants received for free as part of a unit purchase, where your total capital at risk is the $10 per share you can redeem. In that scenario, the warrant is pure upside you received without incremental cost. That's a reasonable trade. Buying warrants separately, in the open market, after the merger is announced, at $2 or $3 each, is a different bet entirely.